Compare
Zone Frontier Inc. vs DSwiss Inc vs Park Ha Biological Technology Co., Ltd. vs Bonk, Inc.
| Latest fiscal year | Zone Frontier Inc. ZONE | DSwiss Inc DQWS | Park Ha Biological Technology Co., Ltd. BYAH | Bonk, Inc. BNKK |
|---|---|---|---|---|
| Year ended | 2026-06-30 | 2025-12-31 | 2025-10-31 | 2025-12-31 |
| Revenue | $3.41M | $2.92M | $2.52M | $2.12M |
| Revenue growth (YoY) | +64.3% | -6.2% | +6.0% | +201.6% |
| Gross margin | 37.8% | 19.3% | 94.4% | 58.5% |
| Operating margin | n/m | 0.0% | -956.5% | n/a |
| Net margin | n/m | -2.6% | -965.0% | n/m |
| Net income | -$174.16M | -$76.9K | -$24.36M | -$68.19M |
| EPS (Diluted) | n/a | $0.00 | -$41.38 | -$17.02 |
| Operating cash flow | -$18.16M | -$94.3K | $85.9K | -$25.28M |
| Free cash flow | -$18.19M | -$135.3K | -$3.0K | n/a |
| Cash & equivalents | $15.44M | $285.0K | $3.79M | n/a |
| Total assets | $52.51M | $677.1K | $5.95M | $40.97M |
| Total liabilities | $994.8K | $686.5K | $1.96M | $5.98M |
| Shareholders' equity | $51.51M | -$9.3K | $3.99M | $35.00M |
| Return on year-end equity | -338.1% | n/a | -609.9% | -194.8% |
| Shares outstanding | n/a | 206.90M | n/a | 7.75M |
Revenue, most recent five fiscal years
| Fiscal year | Zone Frontier Inc. | DSwiss Inc | Park Ha Biological Technology Co., Ltd. | Bonk, Inc. |
|---|---|---|---|---|
| Latest | $3.41M Ended 2026-06-30 | $2.92M Ended 2025-12-31 | $2.52M Ended 2025-10-31 | $2.12M Ended 2025-12-31 |
| 1 year earlier | $2.07M Ended 2025-06-30 | $3.11M Ended 2024-12-31 | $2.38M Ended 2024-10-31 | $702.0K Ended 2024-12-31 |
| 2 years earlier | $1.60M Ended 2024-06-30 | $1.47M Ended 2023-12-31 | $2.46M Ended 2023-10-31 | $202.7K Ended 2023-12-31 |
| 3 years earlier | n/a | $1.85M Ended 2022-12-31 | $1.92M Ended 2022-10-31 | $120.6K Ended 2022-12-31 |
| 4 years earlier | n/a | $1.96M Ended 2021-12-31 | n/a | $2.88M Ended 2021-12-31 |